Paper · 40301571
Cross-tissue MiRNA profiling of extracellular vesicles and PBMCs from amyotrophic lateral sclerosis patients.
Dragoni F and 10 others. Sci Rep, 2025. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cross-tissue MiRNA profiling of extracellular vesicles and PBMCs from amyotrophic lateral sclerosis patients. Papers, record 40301571. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40301571
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cross-tissue MiRNA profiling of extracellular vesicles and PBMCs from amyotrophic lateral sclerosis patients.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyotrophic Lateral Sclerosis | Major topic |
| MicroRNAs | Major topic |
| Extracellular Vesicles | Major topic |
| Leukocytes, Mononuclear | Major topic |
| Humans | |
| Male | |
| Female | |
| Gene Expression Profiling | |
| Middle Aged | |
| Aged | |
| Transcriptome |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35,250,537 | Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35250537 | PubMed |
| 2 | 32,329,299 | The Role of the SLC Transporters Protein in the Neurodegenerative Disorders. | Clin Psychopharmacol Neurosci | 2020 | https://conductscience.org/library/papers/32329299 | PubMed |
| 3 | 29,402,919 | Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients. | Sci Rep | 2018 | https://conductscience.org/library/papers/29402919 | PubMed |
| 4 | 28,960,088 | ADAM10 as a therapeutic target for brain diseases: from developmental disorders to Alzheimer's disease. | Expert Opin Ther Targets | 2017 | https://conductscience.org/library/papers/28960088 | PubMed |
| 5 | 33,922,505 | Role of SNAREs in Neurodegenerative Diseases. | Cells | 2021 | https://conductscience.org/library/papers/33922505 | PubMed |
| 6 | 24,252,274 | Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. | Acta Neuropathol Commun | 2013 | https://conductscience.org/library/papers/24252274 | PubMed |
| 7 | 37,975,900 | Mitochondrial aminoacyl-tRNA synthetases trigger unique compensatory mechanisms in neurons. | Hum Mol Genet | 2024 | https://conductscience.org/library/papers/37975900 | PubMed |
| 8 | 25,683,921 | Ectosomes and exosomes: shedding the confusion between extracellular vesicles. | Trends Cell Biol | 2015 | https://conductscience.org/library/papers/25683921 | PubMed |
| 9 | 26,528,138 | Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 (G93A) mouse model of amyotrophic lateral sclerosis. | Front Cell Neurosci | 2015 | https://conductscience.org/library/papers/26528138 | PubMed |
| 10 | 38,980,441 | Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases. | Acta Neuropathol | 2024 | https://conductscience.org/library/papers/38980441 | PubMed |
1 to 10 of 48
See all 48 referencesCited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,769,109 | The Dual Role of Exosome-Mediated Central-Peripheral Immune Dialogue in Amyotrophic Lateral Sclerosis-Associated Neuroinflammation. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42769109 | PubMed |
| 42,458,453 | Extracellular vesicles as a liquid biopsy for amyotrophic lateral sclerosis: a systematic review and meta-analysis. | J Transl Med | 2026 | https://conductscience.org/library/papers/42458453 | PubMed |
| 42,244,746 | A microRNA atlas of the human prefrontal cortex across the adult lifespan. | bioRxiv | 2026 | https://conductscience.org/library/papers/42244746 | PubMed |
| 41,398,118 | miRNA Biomarkers Diagnose Amyotrophic Lateral Sclerosis in Circulating Blood. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41398118 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ESR2 | 2,100 | PubTator's text mining | https://conductscience.org/library/genes/2100 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40301571
GET https://conductscience.org/api/papers/v1/40301571/references?page=2